# Vera Therapeutics, Inc.: Form DEF 14A, filed Apr 9, 2026

- Company: [Vera Therapeutics, Inc.](/companies/vera.md) (CIK 1831828)
- Form: DEF 14A
- Filed: 2026-04-09
- Accepted by EDGAR: Apr 9, 2026, 16:05 ET
- Period: 2026-05-21
- Accession: 0001140361-26-014002
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1831828/000114036126014002/ny20065346x1_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1831828/000114036126014002/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1831828/000114036126014002/ny20065346x1_def14a.htm

Filed Apr 9, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-014002. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.